Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Pharmaceutical Business Review
Return to: PBR Home

White Papers Directory

Latest White Papers
Haselmeier Establishes New Pen Injector Assembly Facility in India
| By Haselmeier
Haselmeier, a leading designer and manufacturer of pen injection systems, announced that it will establish a new manufacturing facility in Bangalore, India to produce and supply high-quality, competitively priced pen injectors for the pharmaceutical industry in India. The reusable and easy-to-use pen is based on the i-pen technology and designed to allow accurate and reliable dosing.
White Papers
Healthcare and Variable Information Products
| By Avery Dennison
Our portfolio of healthcare and variable information products has been created to meet the requirements for strong shelfappeal, sophisticated packaging, extended content labels, patient and medicine tracking and information.
White Papers
Heightened FDA Enforcement for Sterility Issuesin Pharma Biotech with NSF
| By NSF Health Sciences Pharma Biotech PBR
NSF analysed all of the warning letters issued to pharma and biologic manufacturers for sterility issues since 2015. This white paper provides detailed insight into our analysis. It includes relative charts and a table with a summary of the regulations cited by the FDA as well as recommendations for closing your compliance gaps.
White Papers
Hepatic Impairment Studies in Early Development Services: Innovative Patient Pharmacology Models for Phase I-IIa Support
| By PRA Health Sciences
PRA Early Development Services (EDS) has established a group of experts dedicated to early phase patient studies. Our innovative Patient Pharmacology Services (PPS) features a unique scientific/medical and operational model that enables us to conduct studies in patients with hepatic impairment following the same processes and guidelines that we apply to traditional Phase I or Phase IIa trials.
Contract Research & Services > Contract Research > White Papers
Heraeus Expertise and Services
| By Heraeus
This free white paper gives information on chemical process development, biotech process development and Heraeus' technology platforms.
White Papers
High-End Ethical Pharmaceuticals and Medical Devices
| By Avery Dennison
Products in this range are typically used for highly-sensitive drugs with critical packaging needs such as pre-filled inhalers, syringes and saline bags. Anti-counterfeiting products incorporating UV and holographic features in addition to tamperevident solutions such as destructible films are also included. This section provides information on a number of specialty products including hanging applications, luminescents and security solutions.
White Papers
Highly Active Pharmaceutical Ingredients
| By Sanofi CEPiA
A key activity is the manufacturing of highly active pharmaceutical ingredients (HAP) and cytotoxic compounds. This activity stems from Sanofi’s expertise gained through the manufacturing of taxanes (Docetaxel, Taxotere® and Cabazitaxel, Jevtana®) and in the development of other drugs for oncology. CEPiA is glad to present to customers its dedicated equipment and facilities for highly active products manufacturing.
Production & Manufacturing > Fine & Speciality Chemicals > White Papers
Highly Potent Active Pharmaceutical Ingredients
| By Heraeus
This company brochure provides comprehensive information on Heraeus and its products.
White Papers
HILIC–MS - High Resolution and Sensitivity for the Analysis of Very Polar Compounds
| By Tosoh Bioscience
Hydrophilic interaction liquid chromatography (HILIC) offers unique advantages for mass spectrometric detection of very polar compounds when compared to reversed phase chromatography. The higher organic content of the eluent in HILIC supports efficient evaporation of the solvent, thus enhancing sensitivity and altering ion suppression.
Drug Research > Drug Discovery & Development > White Papers
How 3D Medical Animation Benefits The Healthcare Industry
| By Polygon Medical Animation
From the earliest sketches and drawings of the human anatomy by Leonardo da Vinci to the world of modern visual communication, exploring the wonders of science has never been so beautifully revealed since the dawn of 3D. In the healthcare industry, where customer demands are changing and ever increasing, they have embraced the use of 3D medical animation as a new and effective form of communication to keep abreast with the times.
Drug Research > Drug Discovery & Development > White Papers
How can Nanoparticle Tracking Analysis Assist in the Production of Nanoparticles
| By Malvern Instruments
This white paper highlights the growth in the use of the technique of Nanoparticle Tracking Analysis as applied to nanoparticles and nanomaterials production and analysis, from the very first reports on nanoscale silver and gold (Lundahl et al. (2008) and Marsh et al. (2008), respectively).
White Papers
How Frequently are Predicted Peptides Actually Recognised by CD8 Cells?
| By CTL Laboratories
Detection of antigen-specific CD8 cells relies on the use of peptides that can bind to HLA-Class I molecules. There is extensive knowledge on individual HLA-alleles’ peptide binding requirements and for many antigens immunogenic peptides have been defined. The 32 individual peptides that comprise the CEF peptide pool represent such well-defined peptide determinants for Cytomegalo, Epstein Barr, and Flu virus. We tested 42 healthy human donors on the accuracy of these peptide predictions.
Contract Research & Services > Clinical Trials > White Papers
How Malvern Panalytical helped GSK India optimize their manufacturing process using
| By Malvern Instruments
GSK India is headquartered at Worli, Mumbai with the manufacturing unit being located at Nashik. A second manufacturing facility at Vemgal, Karnataka is due to be completed in 2018.
White Papers
How the Vaisala Continuous Monitoring System Aids Compliance with Title 21 CFR Part 11 and EU GMP Annex 11
| By Vaisala pbr
This white paper outlines how Vaisala’s Continuous Monitoring System helps to meet the requirements of Title 21 CFR Part 11 and EU GMP Annex 11 as they apply to environmental monitoring and validation.
Contract Research & Services > Clinical Trials > White Papers
How to write to Regulatory Agencies when things go wrong
| By NSF Health Sciences Pharma Biotech PBR
Your essential guidance on what to do next after you receive a less than positive regulator's audit report.
White Papers
HPLC Analysis of Fluorescently labelled N-Glycans
| By Ludger
To enable the detection following separation of N-glycans by HPLC, the glycans are flourescently labelled with aryl amine compounds by reductive amination. The most commonly used flourescent label is 2-aminobenzamide (2AB), although 2-aminobenzoic acid (2-AA) and 2-aminopyride (2AP) are also used. The labelled glycans can then be analysed by a range of HPLC methods.
White Papers
HPLC Analysis of lysozyme in different types of wine
| By Tosoh Bioscience
Hen’s egg white lysozyme is used in winemaking to eliminate lactic acid bacteria and to control malolactic fermentation. As eggs and derivatives are regarded as potential allergenics the European Commission issued a directive that wine labels must include information about egg derived ingredients like lysozyme. As a consequence the International Organisation for Wine and Vine (OIV) published a standard method for measurement of lysozyme in wine by HPLC, which is based on a method developed at the University of Bologna.
Drug Research > Drug Discovery & Development > White Papers
HPMC-LACTOSE MIXTURES AS MATRIX FORMERS IN CONTROLLED RELEASE TABLETS: PHYSICAL MIXTURES VS. CO-PROCESSED BLENDS
| By MEGGLE
The main objective of this work was to investigate the effects of the type of preparation method of HPMC/lactose-based matrix tablets on the resulting: 􀂃flowability and compressibility of the powders/granules 􀂃drug release kinetics 􀂃dimension changes 􀂃water uptake/weight loss kinetics of the tablets upon exposure to different release media.
Production & Manufacturing > Fine & Speciality Chemicals > White Papers
Human ADME and Studies with Radiolabeled Compounds: Phase I-IIa
| By PRA Health Sciences
Radiolabeled medication is widely used in the assessment of human ADME and also increasingly in assessing absolute bioavailability (BA). Conducting an ADME study early in the clinical development program - generally before or in parallel with Phase IIa - is prudent since the outcome may generate the need for additional toxicology studies.
Contract Research & Services > Contract Research > White Papers
Humidity measurements in H2 O2
| By Rotronic
The use of resistant relative humidity sensors in hydrogen peroxide sterilisation chambers.
White Papers
Hydrogenation & Catalysis Tools
| By HEL Group
HEL Group’s top quality high pressure reactors and systems offer innovative, robust and flexible solutions to chemists working on various hydrogenation and catalysis applications.
Automation > Laboratory Instrumentation > White Papers
See all White Papers